| Asha R Schweitzer, DO | |
|
2300 S 16th St, Lincoln, NE 68502-3704 | |
| (402) 481-8566 | |
| (402) 481-8805 |
| Full Name | Asha R Schweitzer |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 12 Years |
| Location | 2300 S 16th St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174751820 | NPI | - | NPPES |
| 470553011-00 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 772 (Nebraska) | Secondary |
| 207Q00000X | Family Medicine | 772 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beatrice Community Hospital & Health Center, Inc | Beatrice, NE | Hospital |
| Cox Monett Hospital | Monett, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beatrice Community Hospital And Health Center Inc | 1951208222 | 57 |
| Teledigm Physician Services Llc | 6002130283 | 16 |
| Cox Barton County Hospital | 8820329782 | 21 |
| Cox-monett Hospital Inc | 0345236667 | 50 |
| West Park Hospital District | 7315855624 | 45 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Entity Name | Madonna Rehabilitation Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417045642 PECOS PAC ID: 0446164081 Enrollment ID: O20031118000079 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Entity Name | Inpatient Physician Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699725358 PECOS PAC ID: 2365334364 Enrollment ID: O20040325001149 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Entity Name | Beatrice Community Hospital & Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922111855 PECOS PAC ID: 1951208222 Enrollment ID: O20121214000477 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Entity Name | Teledigm Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667256 PECOS PAC ID: 6002130283 Enrollment ID: O20150116000478 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Entity Name | Grand Island Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225658495 PECOS PAC ID: 0143659508 Enrollment ID: O20200904000271 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Entity Name | Bryan Hospital Kearney |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033875380 PECOS PAC ID: 5991195547 Enrollment ID: O20211214002678 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Asha R Schweitzer, DO 2300 S 16th St, Lincoln, NE 68502-3704 Ph: (402) 481-8566 | Asha R Schweitzer, DO 2300 S 16th St, Lincoln, NE 68502-3704 Ph: (402) 481-8566 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.
› Verified 6 days ago
Rajesh Kumar, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3400 O St, Lincoln, NE 68510 Phone: 402-476-1313 Fax: 402-476-0529 | |
Matthew W Jacobsen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7441 O St, Ste 400, Lincoln, NE 68510 Phone: 402-488-7400 | |
Dr. Michael Armstrong, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4600 Valley Rd Ste 200, Lincoln, NE 68510 Phone: 402-483-4571 Fax: 402-483-5633 | |
Amanda Woodward, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4004 Pioneer Woods Dr, Lincoln, NE 68506 Phone: 402-484-4900 Fax: 402-484-6456 | |
Mrs. Anne Marie Moore, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4720 W Huntington Ave Ste J, Lincoln, NE 68524 Phone: 402-470-6055 Fax: 402-470-6056 | |
Mrs. Emma Sameera Edwards, P.A. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7121 Stephanie Ln Ste 102, Lincoln, NE 68516 Phone: 402-413-5010 Fax: 402-413-5009 | |
Kylie Parshall, PAC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2611 S 70th St, Lincoln, NE 68506 Phone: 402-423-4200 Fax: 402-423-4201 |